RFK Jr. is giving his son any fees he earns from Gardasil vaccine litigation
RFK Jr. said he would give up the fees after senators questioned him about the lawsuits in a pair of hearings.
Related Articles
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
CDC Data Is Disappearing
The agency has already removed scientific data from public view. More could follow.
Exclusive: Musk aides lock government workers out of computer systems at US agency, sources say
Aides to Elon Musk charged with running the U.S. government human resources agency have locked career civil servants out of computer systems that contain the…
GAO: Public-health workforce shortage undermines ability to respond to outbreaks, other emergencies
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A new US Government Accountability Office (GAO) report identifies a shortage of public health workers across multiple occupations and locations…
Trial data support 3 shorter regimens for drug-resistant TB
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis…
US flu activity climbs, with more deaths in kids
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 The nation’s flu activity continued a steady rise last week, with 44 states at the high or very high level…
Removal of HIV- and LGBTQ-Related CDC Webpages Creates Dangerous Gaps in Scientific Information
Due to system maintenance, member access to profiles, IDSA Academy, MyIDSA, and member-only content will be unavailable from Jan. 31 to Feb. 4. We apologize…
RFK Jr. disavows fundraising email that praised HHS freeze, two days after claiming his campaign doesn’t exist
RFK Jr. incorrectly told senators that his presidential campaign no longer existed, before walking back those remarks.
Shionogi Investigational RSV Antiviral Reaches Primary Endpoint for Phase 2 Trial
The company said its oral therapy, S-337395, achieved a 88.94% reduction in viral load.
Systems Immunology Could Provide Insights into Sepsis and Prevent Future Illnesses
Understanding the different types of immune dysregulation that cause sepsis will enable targeted treatments, lower future death tolls, and prevent lingering illness like long COVID-19.